Complications after bladder augmentation in children
AUTOR(ES)
Molina, Carlos Augusto Fernandes, Lima, Gilson José de, Cassini, Marcelo Ferreira, Andrade, Murilo Ferreira de, Facincani, Inalda, Tucci Júnior, Silvio
FONTE
Acta Cir. Bras.
DATA DE PUBLICAÇÃO
2016
RESUMO
PURPOSE : Bladder augmentation is an effective surgical procedure for increasing bladder capacity and reducing pressure on the urinary system. It is indicated for patients with anomalies such as spina bifida, myelomeningocele, urethral valve and bladder exstrophy, who progress with low tolerance of medication. CASES : This was a retrospective study conducted on pediatric patients submitted to bladder augmentation from 2000 to 2011. RESULTS : 34 patients aged 4 to 17 years were submitted to bladder augmentation, 30 of them with an ileal loop and 4 with a ureter.A continent urinary shunt was performed in 16 patients, the Mitrofanoff conduit was associated in 15, and the Macedo technique was used in one. Mean follow-up was 34.35 months (1 to 122 months). Mean creatinine was 1.5 ng/ml (0.4 to 7.5 ng/ml) preoperatively and 1.78 ng/ml postoperatively. Three patients required a renal transplant during follow-up. There was improvement or resolution of vesicoureteral reflux in 83.5% of the kidneys on the right and in 75% on the left. Bladder capacity increased, on average, from 152.5 ml to 410 ml. The main complications were vesical lithiasis in 3 patients and conduit perforation in one. CONCLUSION : Bladder augmentation showed good results in this series, preserving renal function in most of the patients.
Documentos Relacionados
- COMPLICATIONS AFTER TRANSABDOMINAL SOAVE’S PROCEDURE IN CHILDREN WITH HIRSCHSPRUNG’S DISEASE
- Bladder augmentation and urinary diversion in patients with neurogenic bladder: non-surgical considerations
- Complications from injectable materials used for breast augmentation
- Can baseline serum creatinine and e-GFR predict renal function outcome after augmentation cystoplasty in children?
- Using porcine acellular collagen matrix (Pelvicol®) in bladder augmentation: experimental study